Brook F B, Raafat F, Eldeeb B B, Mann J R
Department of Pathology, Children's Hospital, Birmingham, UK.
Hum Pathol. 1988 Aug;19(8):879-88. doi: 10.1016/s0046-8177(88)80002-9.
Forty-one confirmed cases of childhood neuroblastoma diagnosed over a 13-year period were reviewed and reclassified. Most of the tumors were stained using a peroxidase antiperoxidase method for neuron specific enolase (NSE), protein gene product (PGP) 9.5, and S100 protein, all of which have previously been reported to be positive in some neuroblastomas. The relation to prognosis of the histology and immunohistochemistry was studied. There was a significant trend toward improved survival with increasing degree of differentiation, and with decreasing mitosiskaryorrhexis index (MKI) in the stroma-poor group. There was no significant correlation between immunohistochemical staining and survival, although the presence and amount of staining for all three markers tended to increase with tumor differentiation. This study concludes that histologic classification in neuroblastoma is helpful in assessing prognosis but that the clinical features are generally more reliable as indicators of prognosis. The immunohistochemistry of markers used did not contribute towards assessment of prognosis.
回顾并重新分类了在13年期间诊断出的41例儿童神经母细胞瘤确诊病例。大多数肿瘤采用过氧化物酶抗过氧化物酶法对神经元特异性烯醇化酶(NSE)、蛋白基因产物(PGP)9.5和S100蛋白进行染色,所有这些在之前的报道中在一些神经母细胞瘤中呈阳性。研究了组织学和免疫组织化学与预后的关系。在分化程度增加以及基质少的组中,有丝分裂核溶解指数(MKI)降低时,生存有显著改善的趋势。免疫组织化学染色与生存之间无显著相关性,尽管所有三种标志物的染色存在情况和量倾向于随肿瘤分化而增加。本研究得出结论,神经母细胞瘤的组织学分类有助于评估预后,但临床特征作为预后指标通常更可靠。所使用标志物的免疫组织化学对预后评估没有帮助。